Trial · NCT06603142
Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
NCT06603142, Phase 2, Phase 3, Unknown, Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia. Trials, record NCT06603142. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06603142
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
- NCT number
- NCT06603142
- Status
- Unknown
- Phases
- Phase 2, Phase 3
- Enrollment
- 636 participants, estimated
- Lead sponsor
- Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
- Conditions
- Primary Gout, Hyperuricemia
- Interventions
- Febuxostat 20MG Tablets, Febuxostat 20MG Placebo, AR882 25MG, AR882 12.5MG, AR882 25MG Placebo, AR882 12.5MG Placebo, Febuxostat 40MG Tablets, Febuxostat 40MG Placebo
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The percentage of participants with serum uric acid <360 μmol/L | 8 Weeks | |
| Secondary | The percentage of participants with serum uric acid <300, 240 μmol/L | 8 Weeks | |
| Secondary | The percentage of participants with serum uric acid <360, 300, 240 μmol/L | 2, 4, and 6 Weeks | |
| Secondary | The absolute change in serum uric acid levels from baseline | 2, 4, 6, and 8 Weeks | |
| Secondary | The percentage change in serum uric acid levels from baseline | 2, 4, 6, and 8 Weeks | |
| Secondary | Serum uric acid levels | 2, 4, 6, and 8 Weeks | |
| Secondary | Adverse events | 8 Weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06603142
GET https://conductscience.org/api/trials/v1/NCT06603142/registered